Results - Announcements
Rubicon Research Ltd share price remained flat to Rs 1716.55 after the company's net profit saw a marginal increase of 6.66% to Rs 90.43 crore, while revenue from operations improved marginally 7.87% to Rs 576.38 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, gaining 5.04%. It has improved by 2.99% over last one week and gained upto 2.72% in last one month while the market capitalization of Rubicon Research Ltd has gained 11.51% and 11.90% in the same period respectively.
Profit before tax (PBT) of Rubicon Research Ltd stood at Rs 116.92 crore in Q3 FY26, surging by 63.05% year-on-year, and rising 5.93% quarter-on-quarter. EBITDA came in at Rs 142 crore, expanding by 51.49% YoY and advancing by 14.87% sequentially.
Total expenses saw a slight increase of 7.13% to Rs 450.34 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 175.39 crore, going up by 13.94% YoY, while employee benefits expense was at Rs 90.48 crore, ticking higher by 5.61% YoY.
For the TTM ended FY26, revenue from operations soared by 36.57% to Rs 1753.96 crore, while net profit jumped 83.64% to Rs 246.74 crore, compared to previous TTM. EBITDA surged by 26830% to Rs 392.51 crore, and PBT soared 64.78% to Rs 320.53 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 205.05 crore in FY26, as against Rs 159.18 crore in FY25.
Rubicon Research Ltd rallied 164.06% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.